These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32371763)

  • 41. Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension.
    Bönner G; Fuchs W
    Curr Med Res Opin; 2005 Jun; 21(6):935-40. PubMed ID: 15969893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trough:peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/hydrochlorothiazide combination and amlodipine.
    Palatini P; Malacco E; Di SS; Carretta R; Dorigatti F; Bertocchi F; Mann J
    Eur J Clin Pharmacol; 2002 Jan; 57(11):765-70. PubMed ID: 11868797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study.
    Choi Y; Lee S; Cho SM; Kang WH; Nam KY; Jang IJ; Yu KS
    Drug Des Devel Ther; 2016; 10():3021-3028. PubMed ID: 27703330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats.
    Brosnan MJ; Hamilton CA; Graham D; Lygate CA; Jardine E; Dominiczak AF
    J Hypertens; 2002 Feb; 20(2):281-6. PubMed ID: 11821713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative effect of fixed-dose combination tablets of candesartan cilexetil/amlodipine versus olmesartan medoxomil/azelnidipine on laboratory parameters in patients with hypertension: a retrospective cohort study.
    Susa N; Nishida Y; Yada Y; Nakayama T; Asai S; Takahashi Y
    Clin Exp Hypertens; 2016; 38(2):173-9. PubMed ID: 26453437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fixed-dose combination therapy of candesartan cilexetil and amlodipine besilate for the treatment of hypertension in Japan.
    Yasuno S; Fujimoto A; Nakagawa Y; Kuwahara K; Ueshima K
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):577-83. PubMed ID: 22651833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Irbesartan and hydrochlorothiazide association in the treatment of hypertension.
    Derosa G; Ferrari I; Cicero AF
    Curr Vasc Pharmacol; 2009 Apr; 7(2):120-36. PubMed ID: 19355995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients.
    McInnes GT; O'Kane KP; Istad H; Keinänen-Kiukaanniemi S; Van Mierlo HF
    J Hum Hypertens; 2000 Apr; 14(4):263-9. PubMed ID: 10805052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergism of amlodipine and candesartan on blood pressure reduction and organ protection in hypertensive rats.
    Cheng YQ; Tan BY; Yu XH; Dong WZ; Su DF; Zhu DQ; Liu AJ
    Clin Exp Pharmacol Physiol; 2018 Jun; 45(6):514-524. PubMed ID: 29193272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertension.
    Ram CV
    Expert Rev Cardiovasc Ther; 2011 Jan; 9(1):9-19. PubMed ID: 21166525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan.
    Azizi M; Chatellier G; Guyene TT; Ménard J
    J Hypertens; 1999 Apr; 17(4):561-8. PubMed ID: 10404959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic-pharmacodynamic relationships of three angiotensin II receptor antagonists in normal volunteers.
    Burnier M; Buclin T; Biollaz J; Nussberger J; Waeber B; Brunner HR
    Kidney Int Suppl; 1996 Jun; 55():S24-9. PubMed ID: 8743506
    [No Abstract]   [Full Text] [Related]  

  • 53. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats.
    Gorain B; Choudhury H; Kundu A; Sarkar L; Karmakar S; Jaisankar P; Pal TK
    Colloids Surf B Biointerfaces; 2014 Mar; 115():286-94. PubMed ID: 24388859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.
    Bramlage P; Fronk EM; Wolf WP; Smolnik R; Sutton G; Schmieder RE
    Vasc Health Risk Manag; 2015; 11():1-8. PubMed ID: 25565857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis.
    Pfister M; Schaedeli F; Frey FJ; Uehlinger DE
    Br J Clin Pharmacol; 1999 Jun; 47(6):645-51. PubMed ID: 10383542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Candesartan and amlodipine combination therapy provides powerful vascular protection in stroke-prone spontaneously hypertensive rats.
    Takai S; Jin D; Shimosato T; Sakonjo H; Miyazaki M
    Hypertens Res; 2011 Feb; 34(2):245-52. PubMed ID: 21107329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of valsartan/hydrochlorothiazide fixed-dose combination compared with amlodipine monotherapy as first-line therapy for mild to moderate hypertension.
    Chao CL; Lin YH; Lin LC; Lin LY; Tsai CT; Wang YC; Hwang JJ; Chen JC; Chiang FT
    J Int Med Res; 2009; 37(2):289-97. PubMed ID: 19383221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers.
    Hübner R; Högemann AM; Sunzel M; Riddell JG
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S19-25. PubMed ID: 9331000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
    Kim S; Zhan Y; Izumi Y; Iwao H
    Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absence of a pharmacokinetic interaction between losartan and hydrochlorothiazide.
    McCrea JB; Lo MW; Tomasko L; Lin CC; Hsieh JY; Capra NL; Goldberg MR
    J Clin Pharmacol; 1995 Dec; 35(12):1200-6. PubMed ID: 8750372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.